卵巢瘤微环境有助于瘤的进展和化学抵抗
Adriana Ponton-Almodovar1,2,3, Samuel Sanderson1,3, Ramandeep Rattan4
1Precision Health Program, Michigan State University, East Lansing, MI 48824, USA.
Cancer drug resistance (Alhambra, Calif.)
|January 13, 2025
概括
卵巢癌是发生在卵巢中的癌症.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症生物学 癌症生物学
- 瘤微环境研究 研究
背景情况:
- 卵巢癌是一种致命的妇科恶性瘤,复发率高.
- 对基于的化疗 (cisplatin,carboplatin) 的耐药性是一个主要的临床挑战.
- 瘤微环境 (TME) 对卵巢癌的进展和药物耐药性有显著的贡献.
研究的目的:
- 探索瘤微环境 (TME) 在促进卵巢癌化学抵抗方面的作用.
- 为了阐明TME成分和卵巢瘤之间的交叉声如何驱动对基化疗的耐药性.
- 审查针对TME进行卵巢癌治疗的新型治疗策略.
主要方法:
- 关于卵巢癌,瘤微环境和化学抵抗的当前文献的综述.
- 分析特定的TME细胞类型 (纤维细胞,免疫细胞,脂肪细胞,内皮细胞) 的作用.
- 检查化学抵抗中的代谢重编程和细胞外信号.
主要成果:
- TME的组成部分,包括与癌症相关的纤维细胞,免疫细胞,脂肪细胞和内皮细胞,驱动卵巢瘤的进展,入侵和转移.
- 由TME介导的细胞外信号传递和代谢重编程增强了对基化疗的耐药性.
- 准TME组件是一个有前途的治疗策略,可以对抗化学抵抗.
结论:
- 瘤微环境是卵巢癌进展和基于的化疗耐药性的关键决定因素.
- 了解TME内部复杂的交叉通话对于开发有效的卵巢癌治疗方法至关重要.
- 向TME提供了一种新且可行的方法来克服卵巢癌中的化学抵抗.
更多相关视频
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
09:00Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity
Published on: December 31, 2015
26.5K
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Oogenesis
63.4K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.4K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
